R-Biopharm declares take a look at to detect monkeypox virus


Check for analysis functions out there quickly

Darmstadt, Germany, June 1, 2022 – R-Biopharm AG, a number one and globally working biotechnology firm based mostly in Germany, will quickly launch a take a look at for the detection of monkeypox virus. The actual-time PCR take a look at, developed for analysis functions (RUO), shall contribute to trace and management the epidemiological unfold of the virus.

R-Biopharm announces test to detect monkeypox virus

R-Biopharm declares take a look at to detect monkeypox virus

The product is predicted to be out there in roughly two to 3 weeks below the identify RIDA®GENE Monkeypox Virus RUO (half quantity PG4915RUO). Just like the take a look at for the detection of the SARS-CoV-2 virus, which was the primary to be launched by a German firm for analysis functions in February 2020 and was formally accepted for the prognosis of SARS-CoV-2 within the fall of 2020 with the CE mark, the real-time PCR take a look at for the detection of monkeypox virus may even be usable on all widespread real-time PCR devices. The uniform RIDA®GENE design additionally permits customers to run this take a look at along with different RIDA®GENE merchandise.

“R-Biopharm cares concerning the widespread good,” says Dr. Andreas Simons, Head of Product Administration Scientific Diagnostics at R-Biopharm. “That’s why we went proper to work on designing the primers and probes wanted for dependable detection when the primary report got here from the Robert Koch Institute of a case of monkeypox that was not associated to a go to to Africa.”

About R-Biopharm
R-Biopharm AG, situated in Darmstadt, is certainly one of Germany’s main biotechnology firms. It considers itself as a pioneer for well being and high quality of life. The corporate’s aspiration is to supply the best potential precision, security, readability and certainty with wonderful merchandise and options – in prevention, remedy and therapeutic. Analysis and improvement at R-Biopharm has developed agile processes in an effort to tackle new challenges to accompany a steadily rising world inhabitants into a brand new well being period with sustainable options.

As an internationally acknowledged chief, R-Biopharm stands for the event of wonderful applied sciences, merchandise and options within the fields of Scientific Diagnostics, Vitamin Care and Meals and Feed Analytics. R-Biopharm is the worldwide market chief for take a look at techniques within the area of allergen evaluation. The biotechnology firm is thought for its merchandise which might be of excessive significance for human well being. To this finish, it unites improvement, manufacturing and gross sales below one roof and is efficiently represented in additional than 120 nations worldwide – via 28 subsidiaries and 120 distributors. Based in 1988, the family-run firm employs a complete of round 1,300 folks worldwide (690 at its headquarters in Darmstadt) and was repeatedly acknowledged with the “Sustainability Award” for sustainable and worthwhile development. R-Biopharm is cultivating a value-oriented company tradition and administration and is family-run within the second technology. The Chairman of the board of administrators is Christian Dreher.

Image: http://www.apimages.com

Press contact:
Simone Feiler
Head of Company Model Communication
https://r-biopharm.com/
https://r-biopharm.com/news-press/download-gallery/

R-Biopharm AG
An der neuen Bergstraße 17
64297 Darmstadt, Germany
Tel.: +49 61 51 – 81 02-538
Cell: +49 160 – 55 273 60
Fax: +49 61 51 – 81 02-40
Electronic mail: [email protected]



Supply hyperlink

Leave a Reply

Your email address will not be published.